PTAB Will Review Hep B Treatment Co.'s Patent
The Patent Trial and Appeal Board has agreed to review a drug delivery formulation patent owned by Arbutus Biopharma Corp., a company set on curing hepatitis B....To view the full article, register now.
Already a subscriber? Click here to view full article